Tech Company Financing Transactions
Alloy Therapeutics Funding Round
Alloy Therapeutics secured a $42 million Series D funding round on 10/4/2022. Backers included 8VC, Mubadala and Founders Fund.
Transaction Overview
Company Name
Announced On
10/4/2022
Transaction Type
Venture Equity
Amount
$42,000,000
Round
Series D
Investors
Proceeds Purpose
The company intends to use the funds to continue to invest in expanded offerings across all six of its modalities cited below.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
44 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Undisclosed
Website
Email Address
Overview
Alloy Therapeutics is a biotechnology ecosystem company empowering the global scientific community to make better medicines together. Through a community of partners, Alloy democratizes access to tools, technologies, services, and company creation capabilities that are foundational for discovering and developing therapeutic biologics.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Errik Anderson
Chief Operating Officer
Jay Rosanelli
Chief Scientific Officer
Piotr Bobrowicz
VP - Bus. Development
Heather Schwoebel
VP - General Counsel
Patrick Bradley
VP - General Counsel
Logan Snyder
Browse more venture capital transactions:
Prev: 10/4/2022: Comprehensive venture capital transaction
Next: 10/4/2022: Juno venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs